Cyberonics' VNS Therapy System Obtains Regulatory Approval In Japan - Quick Facts

Cyberonics Inc. (CYBX) announced that the Japanese Ministry of Health, Labor and Welfare or MHLW has granted the company final regulatory approval to market and sell its VNS Therapy System for the epilepsy indication. The company plans to launch its VNS Therapy System in Japan following final reimbursement authorization.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com